Walk into most pharmacies or supermarkets and the nutrition advice on offer, whether in the form of supplement recommendations, packaged food marketing, or general dietary guidelines, tends to treat adults as a single undifferentiated category: eat more protein, cut refined sugar, get enough fiber, take a multivitamin. This advice is not wrong so much as it is incomplete in a way that matters considerably more than most consumers, and frankly most retailers, currently appreciate. Nutritional science has built an increasingly precise picture of how dietary requirements shift, sometimes dramatically, across the human lifespan, from the specific micronutrient demands of early childhood growth through the metabolic and absorptive changes of older age, and the gap between that science and the largely one-size-fits-all advice most people actually receive is quietly contributing to preventable disease risk at every life stage.
Early childhood presents perhaps the clearest and best-established case for age-specific nutrition, precisely because the consequences of getting it wrong are so visible and well-documented. The first thousand days, roughly from conception through a child’s second birthday, represent a period of such rapid brain and physical development that specific micronutrient deficiencies, iron, iodine, and certain B vitamins in particular, can produce developmental effects that later nutritional correction cannot fully reverse. This is relatively well understood within pediatric nutrition guidance and public health policy, reflected in fortification programs and targeted supplementation recommendations for pregnant women and young children in many countries, including India’s own nutrition programs, though implementation gaps, particularly around iron and iodine deficiency in lower-income households, remain a significant unaddressed public health burden even where the science itself is well established.
Adolescence introduces a different and less widely appreciated set of demands, driven by the second major growth spurt of human development alongside the onset of puberty, which substantially increases requirements for calcium, iron, particularly in menstruating adolescents, and overall caloric intake relative to body size compared to both younger children and adults. Bone density accumulated during adolescence, driven substantially by adequate calcium and vitamin D intake combined with weight-bearing physical activity, largely determines an individual’s peak bone mass, which in turn is one of the strongest predictors of osteoporosis risk decades later, in a person’s sixties, seventies, and beyond. This means osteoporosis, generally understood and treated as an older-age condition, is substantially determined by nutritional adequacy during a decade of life, adolescence, when it receives comparatively little targeted dietary attention from either healthcare providers or the food and supplement industry.
Adulthood, the life stage most heavily targeted by general nutrition advice and product marketing, is in some respects the stage where individual variation matters most and generic guidance is least useful, since requirements diverge considerably based on activity level, reproductive status, and the early onset of chronic conditions like insulin resistance that benefit substantially from nutritional intervention well before they progress to diagnosable type 2 diabetes. Pregnancy and lactation impose the most dramatic and well-documented shift within adulthood, with substantially elevated requirements for folate, iron, calcium, and overall caloric intake, requirements that generic adult nutrition guidance, built around a non-pregnant, non-lactating baseline, does not remotely capture, which is why pregnancy-specific nutritional guidance exists as a distinct clinical category even though broader adult nutrition advice rarely reflects comparable stage-specific nuance for other significant life transitions.
Older age presents perhaps the widest gap between nutritional need and typical dietary advice, driven by physiological changes that reduce nutrient absorption efficiency even as requirements for certain nutrients, protein in particular, increase relative to younger adulthood rather than decrease as commonly assumed. Sarcopenia, the age-related loss of muscle mass and strength, is now understood to be substantially preventable and even partially reversible through adequate protein intake, generally higher than standard adult protein recommendations, combined with resistance exercise, yet dietary guidance for older adults frequently defaults to lower-calorie, lower-protein recommendations inherited from outdated assumptions about declining activity and metabolic needs rather than the current evidence base. Vitamin B12 absorption also declines significantly with age due to reduced stomach acid production, a well-documented mechanism that nonetheless remains under-screened for in routine geriatric care in many health systems, including India’s, where B12 deficiency in older adults frequently goes undiagnosed until symptoms, including cognitive and neurological effects, become severe enough to prompt investigation.
The public health cost of ignoring these stage-specific shifts is not merely theoretical or diffuse; it shows up in measurable disease burden across the lifespan, from preventable developmental effects in early childhood, through osteoporosis rates substantially higher than adequate adolescent nutrition would produce, to sarcopenia and cognitive decline in older age that current evidence suggests meaningful nutritional intervention, properly targeted, could reduce. Closing the gap between what nutritional science understands about age-specific requirements and what dietary guidance and supplement marketing actually communicate to consumers at each life stage would require a more fundamental shift than most nutrition communication has attempted, treating nutrition guidance as inherently age- and stage-specific from the outset, the way pregnancy nutrition already is, rather than defaulting to general adult recommendations that happen to work reasonably well for some life stages and quietly fail others.
For India specifically, the stakes of closing this gap are unusually high, given that the country simultaneously carries a significant burden of undernutrition in children and a rapidly rising burden of age-related chronic disease among a population that is aging quickly even as public health infrastructure remains geared, in many respects, toward the nutritional challenges of decades past. Pharmaceutical and nutrition companies willing to build genuinely stage-specific products and communication, rather than the currently dominant undifferentiated adult category, have a substantial and largely unaddressed market opportunity in front of them, one that aligns commercial incentive with a public health need that current offerings are only partially meeting.
-V Devaki Nandini
